Fareva is a French pharmaceutical company, with annual revenues of $1.6 billion in 2018, founded and 100% owned by Bernard Fraisse, a French billionaire businessman.[2]
History
It was founded in 1985,[3] and the company now employs 12,500 people. Fareva is the largest contract manufacturing organization (CMO) in France,[4] and of the top five pharmaceutical contract manufacturing organizations in the world. It has over 12,500 employees working in 40 different production sites.[5]
In 2020 the company acquired two biologics facilities from Pierre Fabre; an oncology injectable plant in Pau, Southwest France and a monoclonal antibody (mAb) production facility in Saint-Julien-en-Genevois on the French-Swiss border.[6]
The company is headquartered in Tournon-sur-Rhône, Ardèche, France.[7][8][9]
External links
References
- https://www.pharmaceuticalonline.com/companyprofile/b9fed4de-8c0b-4224-ba98-6dd98338fb00 www.pharmaceuticalonline.com, retrieved 2021-09-15^
- The World's Billionaires: Bernard Fraisse Forbes, retrieved 24 January 2017^
- Bernard Fraisse (Fareva) Capital.fr, retrieved 24 January 2017^
- Interview: Bernard Fraisse - President, Fareva, France Pharmaboardroom.com, 28 April 2016, retrieved 24 January 2017^
- https://www.pharmaceuticalonline.com/companyprofile/b9fed4de-8c0b-4224-ba98-6dd98338fb00 www.pharmaceuticalonline.com, retrieved 2021-09-15^
- Fareva to grow biomanufacturing capabilities - BioProcess Insider BioProcess International, 2021-04-20, retrieved 2021-09-15^
- Ardèche | Le groupe Fareva a inauguré son nouveau siège Ledauphine.com, 16 October 2015, retrieved 24 January 2017^
- Tournon-sur-Rhône | Fareva poursuit sa croissance externe Ledauphine.com, 22 October 2013, retrieved 24 January 2017^
- Etablissement CENTRAGROUP FAREVA ŕ TOURNON SUR RHONE (07300) sur SOCIETE.COM (41976551600101) Societe.com, retrieved 24 January 2017^